Site logo

Uğur Şahin and Özlem Türeci are on the cover of Focus with their new goals

Table of Contents

[ad_1]

prof. Dr. Uğur Şahin and Dr. Özlem Türeci once again became the center of attention of the world media.

Şahin and Türeci Pair took part in the series titled “30 Years Focus, 30 People” of the magazine celebrating its 30th anniversary.

It is stated that mRNA-based vaccines revolutionize medicine.
In the article, for Özlem Türeci and Uğur Şahin, “People who encourage our world set the pace that will make tomorrow’s world a better place.” expressions were used.

BionTech has recently launched personalized mRNA technology. cancer He announced that he had signed an agreement with the British government for their treatment.

Uğur Şahin and Özlem Türeci covered Focus with their new goals - 1

More than 70 experts will work in the R&D center to be established in Cambridge, England.

The company most recently acquired UK-based Artificial Intelligence firm InstaDeep for $680 million.

The company aims to develop new treatments with artificial intelligence for cancer research.

BiontechClinical trials of cancer vaccines with mRNA technology are planned to begin by 2030.

mRNA-based vaccines have the potential to combat many diseases such as Alzheimer’s, dementia, malaria and tuberculosis, apart from Corona virus and cancer.

[ad_2]